Response to authors re commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

David Henry*, Paulina Stehlik, Laura Rosella

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review

2 Citations (Scopus)

Abstract

Brophy and Bally have expressed several concerns about our commentary1 regarding their meta-analysis of observational studies of the use of non-steroidal anti-inflammatory drugs (NSAIDs) and myocardial infarction, published in the BMJ.2 We are grateful for the opportunity to respond to these concerns.
Original languageEnglish
Pages (from-to)675-676
Number of pages2
JournalInternational Journal of Epidemiology
Volume47
Issue number2
DOIs
Publication statusPublished - 30 Mar 2018

Related Research Outputs

  • 2 Citations
  • 1 Article

Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

Stehlik, P., Rosella, L. & Henry, D., 1 Apr 2018, In : International Journal of Epidemiology. 47, 2, p. 362-367 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Cite this